Early experience with topical meloxicam and lidocaine combination for the treatment of vulvodynia

Authors

  • Rufina Kim Queen’s University
  • Kerri-Lynn Kelly Queen’s University
  • Merle Olson University of Alberta
  • J. Curtis Nickel Queen's University

DOI:

https://doi.org/10.5489/cuaj.4976

Abstract

Introduction: We report our early clinical observations on the use of topical meloxicam and lidocaine gel for patients with vulvodynia.

Methods: This is an early experience in participants with a history of vulvodynia evaluated and treated at the Queen’s University Pelvic and Bladder Pain Clinic. Combination meloxicam 0.3% and lidocaine 5% were provided to the participants and they were instructed to apply 5 cc to the vulvar area twice daily. Standardized assessment was conducted for each participant before the start of the topical therapy and again at one week, and included Interstitial Cystitis Symptom Index (ICSI), Interstitial Cystitis Problem Index (ICPI), and pain scoring (Likert) for vulvar pain, in addition to a subjective global assessment after a week of treatment.

Results: Of the eight participants, six had a subjective improvement in their symptoms with the use of the combination gel. They reported between one- and four-point reductions on the Likert pain scale and mild to moderate improvement of symptoms. Common side effects reported were burning and stinging.

Conclusions: The results from this early experience are promising for a potentially effective topical treatment for vulvodynia.

Downloads

Download data is not yet available.

Author Biographies

Rufina Kim, Queen’s University

Student, Department of Urology

Kerri-Lynn Kelly, Queen’s University

Registered Nurse, Department of Urology

Downloads

Published

2018-03-26

How to Cite

Kim, R., Kelly, K.-L., Olson, M., & Nickel, J. C. (2018). Early experience with topical meloxicam and lidocaine combination for the treatment of vulvodynia. Canadian Urological Association Journal, 12(8). https://doi.org/10.5489/cuaj.4976

Issue

Vol. 12 No. 8 (2018): CUAJ August

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.